1. Norma ED. Atherosclerosis-An Inflammatory
Process. J Insur Med 2005; 37: 72-75.
2. Nobukoni Y, Higashikawa F, Miyagawa K, et
al. Hyperlipidemia: Complex Pathophysiology
caused by multiple genetic and environmental
forces in considering the approaches to
preventive medicine. Nippon Eiseigaku Zasshi
2005; 60 (4): 426-41.
3. Shoulder CC, Jones EL, Naoumova RP.
Genetics of familial combined hyperlipidemia
risk of coronary heart disease. Hum Mol
Genet Apr 2004; 1,13 Spec No.1: R 149-160,
Equb; 5.
4. Daniel JR, Helen HH. Disorders of
Lipoprotein metabolism: Harrison’s Principles
of Internal Medicine 18th Edition, McGraw
Hill Medical Publisher Division 2012;2: 3145-
61.
5. Grundy SM, Cleeman JI, Merz CNB, et al.
Implications of recent Clinical trials for the
National Cholesterol Education Program:
Adult Treatment Panel III Guidelines.
Circulation. 2004; 110: 227-39.
6. Lloyd Jones DM, Hong Y, Labartha D, et al.
Defining and setting National goals for
cardiovascular health promotion and disease
reduction. The American Heart Association’s
Strategic Impact goal through 2020 and
beyond. Circulation. 2010; 121: 586-613.
7. Rybicki EP, Chikwamba R, Koch M, Rhodes
JI, et al. Plant-made therapeutics: an emerging
75
Santoshkumar et al., Int J Med Res Health Sci. 2013;2(1):70-77
platform in South Africa. Biotechnol Adv.
2012; 30 (2): 449-59.
8. Nair R, Chanda SV. Antibacterial Activities of
Some Medicinal Plants of the Western
Region of India. Turk J Biol. 2007;31: 231-36.
9. Sultan S, Ahmed S, Sharma S, Jahangir T.
E.officinalis reverse thioacetamide induced
oxidative stress and early promotional events
of primary hepatocarcinogenesis. J Pharma
Pharmacol. 2004; 56(12): 1573-79.
10. Muthuraman A, Sood S, Singla SK. The
antiinflammatory potential of phenolic
compounds from Emblica officinalis L. in rat.
Inflammopharmacology. 2011; 19 (6): 327-34.
11. Prachi J and Shilpa S. Antimicrobial
properties and phytochemical analysis of
Emblica officinalis. Asian J.Exp. Biol.
Sci.2010;1(1):91-95.
12. Poltanov EA, Shikov AN, Dorman HJ,
Pozharitskaya ON, Makarov VG, Tikhonov
VP, Hiltunen R. Chemical and antioxidant
evaluation of Indian gooseberry (Emblica
officinalis Gaertn., syn. Phyllanthus emblica
L.) supplements. Phytother Res. 2009; 23 (9):
1309-15.
13. Madhuri S, Pandey G, Verma KS.
Antioxidant, Immunomodulatory and Anti
cnacer activities of Emblica Officinalis: An
overview. IRJP. 2011; 2 (8):38-42.
14. Rajeshkumar NV, Therese M, Kuttan R.
Emblica officinalis Fruits Afford Protection
against Experimental Gastric Ulcers in Rats.
Therm Biol. 2001;39 (5): 375-80.
15. Akhtar MS, Ramzan A, Ali A, Ahmad M.
Effect of Amla fruit (Emblica officinalis
Gaertn.) on blood glucose and lipid profile of
normal subjects and type 2 diabetic patients.
Int J Food Sci Nutr. 2011; 62 (6): 609-16.
16. Sadaf H, Mohd D, Mohd A, Kunal S, Praveen
KV, Asad UK. Efficacy of E. Officinalis on
the Cariogenic Properties of Streptococcus
mutans: A Novel and Alternative Approach to
Suppress Quorum-Sensing Mechanism. PLoS
ONE 7 (7): e40319
17. Anil UT, Sanjay JS, Manisha PS, and Nehal
HG. Hepatoprotective effect of poly herbal
formulation against various hepatotoxic agents
in rats. Pharmacognosy Res. 2012; 4 (1): 50–
56.
18. Vaidya ADB. Reverse pharmacological
correlates of Ayurvedic drug actions. Indian J
Pharmacol. 2006: 38(5); 311-15.
19. Ghosh MN. Toxicity studies. Fundamental of
Experimental Pharmacology 4th Edition,
Hilton and Company, Calcutta, 2008; 178.
20. Shymala MP, Venukumar MR, Lata MS.
Antioxidant potential of the Syzygium
aromaticum (Gaertn) Linn (Clove) in rats fed
with high fat diet. Indian Journal of
Pharmacology 2003;35:99-103.
21. CPCSEA Guidelines for laboratory animal
facility. Indian J Pharmacol, Special Article.
2003;35, (4): 257-274.
22. Pereira S, Tettamanti M. Ahimsa and
alternatives -- the concept of the 4th R. The
CPCSEA in India. Altex 2005, 22 (1): 3-6.
23. Van HH, Baumans V, Brandt CJ, Boere HA,
Hesp AP, van Lith HA, Schurink M, Beynen
AC. Blood sampling from the retro-orbital
plexus, the saphenous vein and the tail vein in
rats: comparative effects on selected
behavioural and blood variables. Lab Anim.
2001; 35 (2): 131-9.
24. Sarika SS and Aarti GJ. Effects of methanolic
extract of Cuminum cyminum on total serum
cholesterol in ovariectomized rats. Indian J
Pharmacol. 2009; 41 (2): 92–93.
25. Urmila CK, Shraddha NS, Sandesh PJ.
Evaluation of hypoglycemic activity of Cassia
nodosa leaves in normal and streptozotocininduced
diabetic rats. Int J Green Pharm 2012;
6: 9-13.
26. Milada Dobiášová. Atherogenic Index of
Plasma [Log (Triglycerides/HDLCholesterol)]:
Theoretical and Practical
76
Santoshkumar et al., Int J Med Res Health Sci. 2013;2(1):70-77
Implications. Clinical Chemistry July
2004;50(7): 1113-17.
27. Park HR, Park M, Choi J, Park KY, Chung
HY, Lee J. A high-fat diet impairs
neurogenesis: involvement of lipid
peroxidation and brain-derived neurotrophic
factor. Neurosci Lett. 2010; 4 (3): 235-39.
28. Harikrishnan S, Rajeev E, Tharakan JA, Titus
T, Ajit Kumar VK, Sivasankaran S,
Krishnamoorthy KM, Nair K. Efficacy and
safety of combination of extended release
niacin and atorvastatin in patients with low
levels of high density lipoprotein cholesterol.
Indian Heart J. 2008;60(3): 215-22.
29. Etsuo N, Yasukazu Y, Yoshiro S , Noriko N.
lipid peroxidation: Mechanisms, inhibition
and biological effects. Biochemical and
Biophysical Research Communications.
2005;338: 668-76.
30. Boizel R, Laporte F, Benhamou YP, Foulon T,
Lardy B, Halimi S. Ratio of Triglycerides to
HDL Cholesterol as an Indicator of LDL
Particle Size in Patients With Type 2 Diabetes
and Normal HDL Cholesterol Levels.
Diabetes Care. 2000;23(11): 1679-85.
31. Montalcini T, Gorgone G, Federico D,
Emanuele V, Sesti G, Ceravolo R, Pujia A,
Perticone F. Association of LDL cholesterol
with carotid atherosclerosis in menopausal
women affected by the metabolic syndrome.
Nutrition, Metabolism & Cardiovascular
Diseases. 2005; 15: 368-72.
32. Byron JH, Dennis LS, Vijay N. A truly deadly
quartet: obesity, hypertension,
hypertriglyceridemia, and hyperinsulinemia.
Cleveland Clinic Journal of
Medicine.2002;69(12): 989-89.
33. Vinson JA, Liang X, Proch J, Hontz BA,
Dancel J, Sandone N. Polyphenol antioxidants
in citrus juices: in vitro and in vivo studies
relevant to heart disease. Adv Exp Med Biol.
2002;505:113-22.
34. Pietta GP. Flavonoids as Antioxidants. J. Nat.
Prod., 2000, 63 (7): 1035–42.
35. Dhuley JN. Anti oxidant effect of cinnamon
(Cinnamonum verum) bark and greater
cardamom (Amomum subula-tum) seeds in
rats fed with high fat diet. Indian J Exp Boil
1999; 37: 238-42.
36. Mishra M, Pathak UN, Khan AB. E.officinalis
Gaertn and Serum Choesterol level in
experimental rabbits. Br J Exp Pathol. 1981;
62 (5): 526-28.
37. Gulati RK, Aggarwal S, Aggarwal SS.
Hepatoprotective studies on Phyllanthus
emblica Linn and quercetin. Indian Journal of
Experimental Biology. 1995; 33: 261-68.
38. O’Sullivan S. Statins: A review of benefits
and risks. TSMJ. 2007; 8: 52-56.
39. Thomas P B. Drug therapy for
hypercholesterolemia and dyslipidemia. In:
Laurence Burton, Bruce Chabner, Bjorn
Knollman. Goodman & Gilman’s The
Pharmacological Basis of Therapeutics. 12th
Edition. McGraw Hill, New York 2011; 877-
908.
40. Harshmohan. The Blood Vessels and
Lymphatics: The Textbook of Pathology, 4th
Edition. Jaypee Brothers Medical Publisher
(P) Ltd, Mumbai 2000; 252-54.
41. Satoskar RS, Bhandarkar SD, Rege NN.
Appetite stimulants, Digestants, Anti
flatulents, Appetite suppressants and
Hypolipidemic agents. Pharmacology and
Pharmacotherapeutics. 22nd Edition. Popular
Prakashan Pvt Ltd, Mumbai 2011; 571-86.
Thank you for copying data from http://www.arastirmax.com
